Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now

A welcome email is on its way. If you don't see it, please check your junk folder.

SMITHS FALLS, Ontario — Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the Company has mailed (or mailed a notice of internet availability with respect to) its proxy statement and fiscal 2026 annual report to shareholders (collectively, the “Meeting Materials”) for its Annual General and Special Meeting of shareholders (the “Meeting”) scheduled to take place on Friday, September 25, 2026, at 1:00 PM ET , via live audio webcast at www.virtualshareholdermeeting.com/WEED2026 .

Nasdaq listing rules require a quorum of 33 1/3% of outstanding shares entitled to vote, present or by proxy at the Meeting. Given Canopy Growth’s shareholder base, reaching quorum depends on strong participation – if it isn’t met, the Meeting must be adjourned at additional cost to the Company. Shareholders of record as of July 31, 2026, are eligible to vote; we encourage voting in advance even if you plan to attend live.

The Meeting Materials are filed on EDGAR and SEDAR+ under the Company’s profile at www.sedarplus.ca . The annual report is available at: https://canopygrowth.com/agm/ .

The board of directors of the Company (the “Board”) recommends FOR on Items 1-6, and every ONE year on Item 7 (each as described in the Company’s proxy statement):

Your vote matters. Please take a moment to submit it today using one of the convenient options below.

By Mail: Using the prepaid envelope accompanying the Form of Proxy or Voting Instruction Form

Canopy Growth is a leading global company committed to bettering lives through cannabis. With a focus on cultivation excellence, quality, trust, innovation and disciplined execution, Canopy Growth is a consumer-centric company serving patients, consumers and partners alike.

The Company’s portfolio of owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL and R’belle, as well as category-defining Storz & Bickel, delivers innovative cannabis products to consumers across Canada and beyond. It is also Canada’s leading provider of medical cannabis services through Spectrum Therapeutics, Abba Medix, Apollo, and Canada House Clinics.

The Company also holds an unconsolidated, non-controlling interest in Canopy USA, LLC, which provides exposure to the U.S. THC market.

Guided by its commitment to leadership, excellence, trust and innovation, Canopy Growth is working to shape a future where the plant is trusted for its ability to better lives.